Ammar Rikabi1, Sufia Hussain. 1. Department of Pathology, College of Medicine. King Saud University, Riyadh, Kingdom Saudi Arabia.
Abstract
OBJECTIVE: To evaluate the usefulness of Tru-Cut biopsy (TCB) in the diagnosis of breast lesions. METHODS: An observational non-interventional cross-sectional review was performed of all TCB reports of a mass or lesion observed in patients admitted between January 2008 and December 2010, at King Khalid University Hospital, Riyadh, Saudi Arabia. RESULTS: A total of 275 trucut biopsies were performed during the study period. Histopathology showed 92 (33.5%) malignant lesions, 177 (64.3%) benign lesions and 6 (2.2%) suboptimal or suspicious lesions. Repeat trucut biopsies were done in 29 (16.4%) of the benign cases, 12 (13%) of the malignant cases, and for 6 inconclusive specimens which showed 4 of the 29 benign cases to be malignant lesions, and 5 of the 6 inconclusive cases were also malignant lesions. All 12 malignant cases that had repeat trucut biopsy had a confirmed diagnosis of malignancy. Trucut biospy had a sensitivity of 95.1%, specificity of 100%, positive predictive value of 100%, negative predictive value of 97.2%, and an overall diagnostic accuracy of 98.2%. CONCLUSION: Trucut biopsy is an accurate alternative to fine needle aspiration cytology in the diagnosis of breast lesions with a high diagnostic accuracy of 98.2%.
OBJECTIVE: To evaluate the usefulness of Tru-Cut biopsy (TCB) in the diagnosis of breast lesions. METHODS: An observational non-interventional cross-sectional review was performed of all TCB reports of a mass or lesion observed in patients admitted between January 2008 and December 2010, at King Khalid University Hospital, Riyadh, Saudi Arabia. RESULTS: A total of 275 trucut biopsies were performed during the study period. Histopathology showed 92 (33.5%) malignant lesions, 177 (64.3%) benign lesions and 6 (2.2%) suboptimal or suspicious lesions. Repeat trucut biopsies were done in 29 (16.4%) of the benign cases, 12 (13%) of the malignant cases, and for 6 inconclusive specimens which showed 4 of the 29 benign cases to be malignant lesions, and 5 of the 6 inconclusive cases were also malignant lesions. All 12 malignant cases that had repeat trucut biopsy had a confirmed diagnosis of malignancy. Trucut biospy had a sensitivity of 95.1%, specificity of 100%, positive predictive value of 100%, negative predictive value of 97.2%, and an overall diagnostic accuracy of 98.2%. CONCLUSION: Trucut biopsy is an accurate alternative to fine needle aspiration cytology in the diagnosis of breast lesions with a high diagnostic accuracy of 98.2%.
Entities:
Keywords:
Breast Cancer; Saudi Arabia; Tru-Cut Biopsy
Authors: Maribel D Lacambra; Christopher C Lam; Paulo Mendoza; Siu Ki Chan; Alex M Yu; Julia Y S Tsang; Puay Hoon Tan; Gary M Tse Journal: Breast Cancer Res Treat Date: 2011-06-23 Impact factor: 4.872
Authors: Francesca Buonomo; Sofia Bussolaro; Clarice de Almeida Fiorillo; Danilo Oliveira de Souza; Fabiola Giudici; Federico Romano; Andrea Romano; Giuseppe Ricci Journal: J Clin Med Date: 2022-04-30 Impact factor: 4.964
Authors: Abdulkhaleq A Binnuhaid; Sultan Abdulwadoud Alshoabi; Fahad H Alhazmi; Tareef S Daqqaq; Suliman G Salih; Sami A Al-Dubai Journal: J Family Med Prim Care Date: 2019-12-10